• A comprehensive exploration of chronic kidney disease and dialysis in Canada's Indigenous population: from epidemiology to genetic influences
• Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: a comprehensive review of current evidence: communication from the ISTH SSC on perioperative and critical care thrombosis and hemostasis
• Acute Abdominal Crisis in Type A Hemophilia: Unraveling Retroperitoneal Hematoma: A Case Report
• ADAMTS13 in the New Era of TTP
• Advances in the treatment of thrombotic thrombocytopenic purpura
• Analysis of factors influencing onset and survival of patients with severe acute pancreatitis: A clinical study
• Analytical and Clinical Validation of a Non-Ristocetin Based VWF Assay on 2 Automated Analyzers in a Large Reference Laboratory
• Analyzing Pooled Microarray Gene Expression Data to Uncover Common Pathways in Periodontitis and Oral Squamous Cell Carcinoma from the Gene Expression Omnibus
• Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic Substudy
• Association of cigarette smoking with cardiometabolic risk factors: A cross-sectional study
• Atypical Presentations of Pediatric-acquired Thrombotic Thrombocytopenic Purpura
• Biochemical and Histological Differences between Longitudinal and Vertical Fibres of Dupuytren's Palmar Aponeurosis and Innovative Clinical Implications
• Bleeding in valvular heart disease: is von Willebrand factor the culprit?
• Bleeding Mystery Unveiled: A Case of Acquired Hemophilia A in the Shadow of Multiple Myeloma
• Blood coagulation in Prediabetes clusters-impact on all-cause mortality in individuals undergoing coronary angiography
• Carbamylation is instrumental in end-stage kidney disease (ESRD) coagulopathies: the impact on von Willebrand factor and platelet functionality
• Carbamylation Is Instrumental in End-Stage Kidney Disease Coagulopathies: The Impact on von Willebrand Factor and Platelet Functionality
• Cardiorespiratory Fitness Is Associated with Decreased Platelet Reactivity
• Changes of the serum properties and its effect on the endothelial cells restoration in patients with chronic disease treated with sulodexide
• Changes of the serum properties and its effect on the endothelial cells restoration in patients with chronic venous disease treated with sulodexide
• Combined coagulation and inflammation markers as predictors of venous thrombo-embolism and death in COVID-19
• Computer based visualization of clot structures in extracorporeal membrane oxygenation and histological clot investigations for understanding thrombosis in membrane lungs
• Correction to: Von Willebrand's disease in breast surgery: case report
• Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines
• Development of a major histocompatibility complex class II conditional knockout mouse to study cell-specific and time-dependent adaptive immune responses in peripheral nerves
• Development of Autoimmune Diseases Among Children With Pediatric Acute-Onset Neuropsychiatric Syndrome
• Dexmedetomidine ameliorates x-ray-induced myocardial injury via alleviating cardiomyocyte apoptosis and autophagy
• Distinct profile of antiviral drugs effects in aortic and pulmonary endothelial cells revealed by high-content microscopy and cell painting assays
• Editorial: Prediction of decompensation/death in advanced chronic liver disease with vWF: Non-invasive vascular factors trump liver function
• Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease
• Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review
• Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure
• Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study
• Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology
• Exploring the Causal Relationship Between Coagulation Function and Gestational Diabetes Mellitus Through Mendelian Randomization
• Exposure-Response Relationship between VWF/FVIII Activity and Spontaneous Bleeding Events Following Recombinant VWF Prophylaxis in Severe VWD
• EXPRESS: Soluble Fms-Like Tyrosine Kinase-1 as an Endothelial Dysfunction Biomarker Associated with Pulmonary Hypertension in Adult Patients with Beta-Thalassemia Major
• Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what's new on the horizon?
• Future directions for xenotransplantation in lungs
• Haemostatic management of von Willebrand disease during childbirth with a plasma-derived VWF/FVIII concentrate
• Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate
• High-Dimensional Single-Cell Mass Cytometry Demonstrates Differential Platelet Functional Phenotypes in Infants With Congenital Heart Disease
• Identification and optimisation of perioperative factors for patients with von Willebrand disease undergoing elective total hip and knee arthroplasty
• Imbalance in the vWF - ADAMTS13 axis exists early in acute pancreatitis and predicts persistent organ failure and pancreatic necrosis-a prospective study
• Imbalance of the von Willebrand Factor - ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)
• Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review
• Immune Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, Therapy and Open Issues
• Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis
• Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis
• Interrogating a Compound Library in Search of an Inhibitor for TREM-like Transcript-1 to Fibrinogen Binding
• Intravenous Immunoglobulin offers temporary improvement in acquired von Willebrand syndrome due to monoclonal gammopathy: A case report
• Investigation of von Willebrand factor multimer abnormalities before and after aortic valve replacement using the Hydragel-5 assay
• Isaridin E Protects against Sepsis by Inhibiting Von Willebrand Factor-Induced Endothelial Hyperpermeability and Platelet-Endothelium Interaction
• Laparoscopic liver resection for a patient of hepatocellular carcinoma with von Willebrand disease: a case report
• Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease
• Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply
• LncRNA MALAT1 facilitates BM-MSCs differentiation into endothelial cells and ameliorates erectile dysfunction via the miR-206/CDC42/PAK1/paxillin signalling axis
• Longitudinal transcriptomic analysis reveals persistent enrichment of iron homeostasis and erythrocyte function pathways in severe COVID-19 ARDS
• Matched cohort study evaluating the hemostatic efficacy of fibrin sealant versus conventional approaches following dental surgery in patients with hemophilia
• Neutrophil NLRP3 promotes cardiac injury following acute myocardial infarction through IL-1β production, VWF release and NET deposition in the myocardium
• Novel GPIb-independent platelet aggregation induced by botrocetin: Implications for diagnosis and antithrombotic therapy
• Occult von Willebrand Disease Complicating Mohs Surgery
• Oral Anticoagulation for Atrial Fibrillation After TAVR: Is Vitamin K Antagonist Still the Primary Option?
• Percutaneous Left Atrial Appendage Closure in a Patient With Acquired Von Willebrand Disease and Atrial Fibrillation
• Persistent Gastrointestinal Bleeding after Aortic Valve Replacement in Heyde's Syndrome
• Pilot Assessment of Platelet Thrombus Area and Contractile Force in Pediatric Congenital Heart Surgery Patients Using a Microfluidic Device
• Plasma von Willebrand factor levels in patients with cancer: A meta-analysis
• Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review
• Prevalence and characterization of anti-VWF antibodies in a population of subjects with type 3 VWD
• Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis
• Primary Total Knee Arthroplasty in Hemophilia and Allied Disorders: Revision Rates and Their Causes
• Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19
• Prognostic Impact of High-Molecular-Weight von Willebrand Factor Multimer Ratio in Classical Low-Flow Low-Gradient Aortic Stenosis
• Psychometrics of patient-reported outcomes measurement information system in von Willebrand disease, inherited platelet function disorders, and rare bleeding disorders
• R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI
• R1205H (Vicenza) causes conformational changes in the VWF-D'D3 domains and enhances VWF binding to clearance receptors LRP1 and SR-A1
• Rare inherited coagulation disorders: no longer orphan and neglected
• Rare VPS33B gene mutation combined with GP1BA mutation causes severe decrease in plasma VWF levels: a case report and literature review
• Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy
• Review of interventions and effectiveness for heavy menstrual bleeding in women with moderate and severe von Willebrand disease
• Risk Factors for Cerebral Vasospasm After Subarachnoid Hemorrhage: A Systematic Review of Observational Studies
• Serum levels of biomarkers related to severity staging of Raynaud's phenomenon, neurosensory manifestations, and vibration exposure in patients with hand-arm vibration injury
• Staged Retrograde Intraoperative Enteroscopy: Description of the 5-Step Surgical Technique for the Diagnosis and Treatment of Small Bowel Bleeding
• The <em>MUC2</em> Gene Product: Polymerisation and Post-Secretory Organisation-Current Models
• The advent of a pan-collagenous CLOVIS POINT for pathotropic targeting and cancer gene therapy, a retrospective
• The effect of ADAMTS13 on graft-versus-host disease
• The effect of flow-derived mechanical cues on the growth and morphology of platelet aggregates under low, medium, and high shear rates
• The history of thrombotic thrombocytopenic purpura research: a narrative review
• The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma
• The Use of Middle Meningeal Artery Embolization to Treat Chronic Subdural Hematoma in the Pediatric Population: A Review of the Literature
• Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs
• Unexpected massive bleeding during the modified LeFort III advancement surgery for Crouzon syndrome: A case report
• Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study
• Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease
• von Willebrand disease
• Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma
• Von Willebrand factor exacerbates heart failure through formation of neutrophil extracellular traps
• Von Willebrand factor: how unique structural adaptations support and coordinate its complex function
• Weibel-Palade bodies: function and role in thrombotic thrombocytopenic purpura and in diarrhea phase of STEC-hemolytic uremic syndrome
• Xuefu Zhuyu decoction alleviates deep vein thrombosis through inhibiting the activation of platelets and neutrophils via sirtuin 1/nuclear factor kappa-B pathway